LaNova Medicines Zhejiang Co., Ltd.
LaNova Medicines Zhejiang Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma. | Locally Advanced or Metastatic GC and GCJ Adenocarcinoma | Active, not recruiting | Phase 3 | 2026-02-06 | NCT06351020 | |
| A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study | Malignant Neoplasms of Digestive Organs | Recruiting | Phase 2 | 2025-09-12 | NCT05934331 |